Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Hyloris Pharmaceuticals SA"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 304.76% vs 133.33% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 59.09% vs -29.41% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.50",
          "val2": "2.10",
          "chgp": "304.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-7.00",
          "val2": "-17.60",
          "chgp": "60.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "-0.20",
          "chgp": "150.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-6.30",
          "val2": "-15.40",
          "chgp": "59.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-905.80%",
          "val2": "-8,611.90%",
          "chgp": "770.61%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

8.50

2.10

304.76%

Operating Profit (PBDIT) excl Other Income

-7.00

-17.60

60.23%

Interest

0.10

0.10

Exceptional Items

0.10

-0.20

150.00%

Consolidate Net Profit

-6.30

-15.40

59.09%

Operating Profit Margin (Excl OI)

-905.80%

-8,611.90%

770.61%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 304.76% vs 133.33% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 59.09% vs -29.41% in Dec 2023

All Annual Results